To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Robin Johnson, PharmD, Gene Therapy Submissions Lead ...
Since the peak of the Covid pandemic, the story of the life sciences market has been a tale of opposing forces. On one hand, the pace of innovation continues to accelerate and there is greater demand ...
Even medical research isn’t immune to a federal overhaul. The life sciences have joined DEI efforts, climate laws and immigration policies as a subject for scrutiny under the agenda of President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results